In rodents, circulating levels of resistin are increased in obesity, and have been demonstrated to play a role in mediating hepatic and skeletal muscle insulin resistance and in the regulation of glucose metabolism through AMP activation [14–19]. Here, RETN is linked to obesity disorder.